Valuation (88%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.97 | N/A |
| PEG Ratio (TTM) | 0.22 | N/A |
| P/S Ratio (TTM) | 13.29 | N/A |
| P/B Ratio (TTM) | 0.79 | N/A |
| P/FCF Ratio (TTM) | 13.00 | N/A |
| Price to 5YR AVG Earnings Ratio | 17.21 | N/A |
| Price to 5YR AVG FCF Ratio | 13.35 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.07% | N/A |
| ROE (TTM) | 3.60% | N/A |
| Net Profit Margin (TTM) | 71.46% | N/A |
| ROIC 5YR AVG | -0.45% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 49.52% | 251.89% | 147.80% |
| Revenue | 35.07% | 350.63% | 192.26% |
| Net Income | 67.29% | 274.29% | 163.49% |
| Cash Flow | 123.72% | N/A | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.34 | N/A |
| Quick Ratio (TTM) | 0.34 | N/A |
| D/E Ratio (TTM) | 0.13 | N/A |
| Interest Coverage (TTM) | 10.21 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.59 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 0.14% | N/A |